NL-OMON47904尚未招募不适用
Pathogenic Antibodies and (Rapidly Progressive) Dementia syndromes - PARADE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Patients aged >= 18 years
- •- Patients who have given written informed consent
- •- patients with a clinical profile that fits one the described groups (rapidly progressive dementia of atypical dementia syndromes)
排除标准
- •- Age below 18 years
- •- Patient objects after initial informed consent
- •- Patient with mild cognitive impairment (MCI), subjective memory complaints or vascular dementia
研究者
相似试验
尚未招募
不适用
Immune-mediated pathogenesis and development of autoimmunity in neurological manifestations of COVID-19ONG COVID, cognitive deficits during COVID-19 infection, psychiatric disease after COVID-19 infection, immunological marker and divergence in serum and cerebro spinal fluid during COVID infectionU07.1COVID-19, virus identifiedDRKS00024434niversity of Cologne150
尚未招募
不适用
Human body Immunity for Scrub typhus infectioCTRI/2019/08/020822Christian Medical College
招募中
不适用
Early phase development of antibodies against biologicals in rheumatoid arthritis patientsRheumatoid arthritis Anti-drug antibodies BiologicalsReumatoide artritis Antistoffen BiologicalsNL-OMON25457Academisch Medisch Centrum280
已完成
不适用
Early phase development of anti-drug-antibodies in rheumatoid arthritis patients10023213Rheumatoid arthritisNL-OMON43545Academisch Medisch Centrum280
招募中
不适用
Occurrence of Anti-drug antibody and change of drug level for 1 year after CT-P13 therapy and their Impact on clinical outcomes in moderate to Severe inflammatory bowel diseaseKCT0002222Kangbuk Samsung Medical Center300
